GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2007

Clinical Data Purchases Protedyne’s Radius Platform

  • Clinical Data’s ( Cogenics division bought Protedyne’s ( Radius automation system. “This new equipment is required for the higher throughput studies that our clients are demanding,” points out Robert Bondaryk, Cogenics’ general manager. “This platform strongly supports current tests, such as Familion Long QT, and the continuing rollout of new CLIA sequencing tests launched by Clinical Data's PGxHealth Division.” Radius is a benchtop automation platform designed with a radial arm to provide the highest level of flexibility built to ensure reliability, superior speed, and unmatched precision, says Pete Massaro, CTO of Protedyne.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »